Mechanism of Action GLP-1 monotherapy, GLP-1/GIP, GLP-1/glucagon, triple agonists, amylin combinations, GIP receptor antagonists Route of Administration Injectables, oral peptides, oral small molecules Dosing Frequency Once daily, once weekly, once monthly Therapeutic Goals Glycemic control, weight management, cardiovascular risk reduction, renal protection, MASH, sleep apnea, etc
Remember, consulting healthcare providers for personalized guidance is essential in managing any medication-related side effects effectively
Anyone promising rapid results is misleading you
These novel delivery strategies not only enhance drug bioavailability but also offer sustained release and improved patient compliance, which are essential for effective treatment of cerebral ischemia